6-K, 6-K/A, 8-K, 8-K/A, 10-C
Filing Types
GW Pharmaceuticals PLC
Companies

137 filings

Newest first
8-K
GWPH GW Pharmaceuticals PLC
6 Aug 19
Results of Operations and Financial Condition
8-K
GWPH GW Pharmaceuticals PLC
26 Jul 19
Other Events
8-K
GWPH GW Pharmaceuticals PLC
13 Jun 19
Submission of Matters to a Vote of Security Holders
8-K
GWPH GW Pharmaceuticals PLC
13 Jun 19
Regulation FD Disclosure
8-K
GWPH GW Pharmaceuticals PLC
6 May 19
Results of Operations and Financial Condition
8-K
GWPH GW Pharmaceuticals PLC
12 Apr 19
Departure of Directors or Certain Officers
8-K
GWPH GW Pharmaceuticals PLC
8 Apr 19
Completion of Acquisition or Disposition of Assets
8-K
GWPH GW Pharmaceuticals PLC
18 Mar 19
GW Pharmaceuticals plc Announces the Sale of Priority Review Voucher for $105M
8-K
GWPH GW Pharmaceuticals PLC
26 Feb 19
Results of Operations and Financial Condition
8-K
GWPH GW Pharmaceuticals PLC
7 Jan 19
Regulation FD Disclosure
8-K
GWPH GW Pharmaceuticals PLC
27 Nov 18
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
8-K
GWPH GW Pharmaceuticals PLC
26 Nov 18
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
8-K
GWPH GW Pharmaceuticals PLC
5 Oct 18
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs
8-K
GWPH GW Pharmaceuticals PLC
1 Oct 18
Other Events
6-K
GWPH GW Pharmaceuticals PLC
27 Sep 18
Current report (foreign)
6-K
GWPH GW Pharmaceuticals PLC
21 Sep 18
Current report (foreign)
6-K
GWPH GW Pharmaceuticals PLC
7 Aug 18
Index to Condensed Consolidated Financial Statements
6-K
GWPH GW Pharmaceuticals PLC
25 Jun 18
Current report (foreign)
6-K
GWPH GW Pharmaceuticals PLC
24 May 18
Current report (foreign)
6-K
GWPH GW Pharmaceuticals PLC
8 May 18
Index to Condensed Consolidated Financial Statements